Literature DB >> 28024406

The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.

Mitsugu Araki1, Narutoshi Kamiya1,2, Miwa Sato3, Masahiko Nakatsui1,4, Takatsugu Hirokawa5,6, Yasushi Okuno1,4.   

Abstract

Accurate prediction of binding affinities of drug candidates to their targets remains challenging because of protein flexibility in solution. Conformational flexibility of the ATP-binding site in the CDK2 and ERK2 kinases was identified using molecular dynamics simulations. The binding free energy (ΔG) of twenty-four ATP-competitive inhibitors toward these kinases was assessed using an alchemical free energy perturbation method, MP-CAFEE. However, large calculation errors of 2-3 kcal/mol were observed using this method, where the free energy simulation starts from a single equilibrated conformation. Here, we developed a new ΔG computation method, where the starting structure was set to multiconformations to cover flexibility. The calculation accuracy was successfully improved, especially for larger molecular size compounds, leading to reliable prediction of a broader range of drug candidates. The present study demonstrates that conformational flexibility of interactions between a compound and the glycine-rich loop in the kinases is a key factor in ΔG estimation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28024406     DOI: 10.1021/acs.jcim.6b00398

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  10 in total

1.  Flex ddG: Rosetta Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation.

Authors:  Kyle A Barlow; Shane Ó Conchúir; Samuel Thompson; Pooja Suresh; James E Lucas; Markus Heinonen; Tanja Kortemme
Journal:  J Phys Chem B       Date:  2018-02-15       Impact factor: 2.991

Review 2.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

3.  E487K-Induced Disorder in Functionally Relevant Dynamics of Mitochondrial Aldehyde Dehydrogenase 2.

Authors:  Shigeyuki Matsumoto; Mitsugu Araki; Yuta Isaka; Fumie Ono; Kenshiro Hirohashi; Shinya Ohashi; Manabu Muto; Yasushi Okuno
Journal:  Biophys J       Date:  2020-07-10       Impact factor: 4.033

4.  A secondary RET mutation in the activation loop conferring resistance to vandetanib.

Authors:  Takashi Nakaoku; Takashi Kohno; Mitsugu Araki; Seiji Niho; Rakhee Chauhan; Phillip P Knowles; Katsuya Tsuchihara; Shingo Matsumoto; Yoko Shimada; Sachiyo Mimaki; Genichiro Ishii; Hitoshi Ichikawa; Satoru Nagatoishi; Kouhei Tsumoto; Yasushi Okuno; Kiyotaka Yoh; Neil Q McDonald; Koichi Goto
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

5.  Uncertainty Quantification in Alchemical Free Energy Methods.

Authors:  Agastya P Bhati; Shunzhou Wan; Yuan Hu; Brad Sherborne; Peter V Coveney
Journal:  J Chem Theory Comput       Date:  2018-05-02       Impact factor: 6.006

6.  Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations.

Authors:  Shinnosuke Ikemura; Hiroyuki Yasuda; Shingo Matsumoto; Mayumi Kamada; Junko Hamamoto; Keita Masuzawa; Keigo Kobayashi; Tadashi Manabe; Daisuke Arai; Ichiro Nakachi; Ichiro Kawada; Kota Ishioka; Morio Nakamura; Ho Namkoong; Katsuhiko Naoki; Fumie Ono; Mitsugu Araki; Ryo Kanada; Biao Ma; Yuichiro Hayashi; Sachiyo Mimaki; Kiyotaka Yoh; Susumu S Kobayashi; Takashi Kohno; Yasushi Okuno; Koichi Goto; Katsuya Tsuchihara; Kenzo Soejima
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-01       Impact factor: 11.205

7.  Improvement in predicting drug sensitivity changes associated with protein mutations using a molecular dynamics based alchemical mutation method.

Authors:  Fumie Ono; Shuntaro Chiba; Yuta Isaka; Shigeyuki Matsumoto; Biao Ma; Ryohei Katayama; Mitsugu Araki; Yasushi Okuno
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

8.  Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.

Authors:  Takahiro Yoshizawa; Ken Uchibori; Mitsugu Araki; Shigeyuki Matsumoto; Biao Ma; Ryo Kanada; Yosuke Seto; Tomoko Oh-Hara; Sumie Koike; Ryo Ariyasu; Satoru Kitazono; Hironori Ninomiya; Kengo Takeuchi; Noriko Yanagitani; Satoshi Takagi; Kazuma Kishi; Naoya Fujita; Yasushi Okuno; Makoto Nishio; Ryohei Katayama
Journal:  NPJ Precis Oncol       Date:  2021-04-16

9.  Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs.

Authors:  Tatsuki Negami; Mitsugu Araki; Yasushi Okuno; Tohru Terada
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

10.  Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer.

Authors:  Hayato Mizuta; Koutaroh Okada; Mitsugu Araki; Jun Adachi; Ai Takemoto; Justyna Kutkowska; Kohei Maruyama; Noriko Yanagitani; Tomoko Oh-Hara; Kana Watanabe; Keiichi Tamai; Luc Friboulet; Kazuhiro Katayama; Biao Ma; Yoko Sasakura; Yukari Sagae; Mutsuko Kukimoto-Niino; Mikako Shirouzu; Satoshi Takagi; Siro Simizu; Makoto Nishio; Yasushi Okuno; Naoya Fujita; Ryohei Katayama
Journal:  Nat Commun       Date:  2021-02-24       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.